TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is a non-invasive alternative to surgery to control primary renal cell cancer (RCC) in patients that are medically inoperable or at high-risk of post-surgical dialysis. The objective of the FASTRACK II clinical trial is to investigate the ef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Siva, Shankar, Chesson, Brent, Bressel, Mathias, Pryor, David, Higgs, Braden, Reynolds, Hayley M., Hardcastle, Nicholas, Montgomery, Rebecca, Vanneste, Ben, Khoo, Vincent, Ruben, Jeremy, Lau, Eddie, Hofman, Michael S., De Abreu Lourenco, Richard, Sridharan, Swetha, Brook, Nicholas R., Martin, Jarad, Lawrentschuk, Nathan, Kron, Tomas, Foroudi, Farshad
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199711/
https://ncbi.nlm.nih.gov/pubmed/30352550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4916-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados